Press Releases

HEALINX CLOSES $13.1 MILLION IN SERIES D FINANCING

U.S. Venture Partners lead round which includes Venrock Associates, e.Lilly Venture Fund, SI Venture Management, Concord Venture Management

Alameda, CA, August 20, 2001 -- Healinx Corporation, the premier provider of Web-based, doctor-patient communication services, today announced that it has closed its Series D round of venture capital financing. To date, the company has raised $41.4 million in investment capital, of which, $13.1 million was raised in the Series D round. The round was led by U.S. Venture Partners and includes Venrock Associates, e.Lilly Venture Fund (a business division of Eli Lilly and Company), SI Venture Management (a Gartner Group affiliate), and Concord Venture Management, and will be used for product development, operations, and sales initiatives. Newton F. Crenshaw, vice president, e.Lilly will join the Healinx Board of Directors.

"Healinx has become the established leader in the rapidly growing market for online doctor-patient communication services," said Philip M. Young, general partner at U.S. Venture Partners. "Reimbursement is key to the development of this market, and Healinx has established solid relationships with both leading third party payors and leading self-insured employers who have selected Healinx for ground-breaking pilots of reimbursed online webVisit™ consultations. This leadership position in reimbursed services, combined with a strong management team and significant market opportunity, makes Healinx an exciting investment. We believe that Healinx will dominate this market as it continues to grow in the next few years."

The Healinx™ service moves beyond e-mail or simple messaging to enable secure, structured, auditable communication between patients and doctors with the goal of improving care and satisfaction, enhancing the doctor-patient relationship, and making healthcare more accessible. Using the Healinx service, patients can conduct webVisit™ consultations, receive prescriptions and renewals, schedule appointments, review their medical profiles, and receive individualized healthcare information online.

"With our focus on investing in innovation and excellence, Healinx is an outstanding addition to our portfolio of companies," said Newton Crenshaw, vice president of e.Lilly. "Healinx's best-of-breed technology for online doctor-patient communication goes hand-in-hand with Lilly's expanding portfolio of best-in-class medical products."

"Our online link between doctors and patients revolutionizes the practice of medicine and benefits thousands of lives every day. Through Healinx's services, doctors can communicate directly with their patients anytime, anywhere. With this new investment capital, Healinx will continue to lead from the front, excelling with first-to-market solutions to new challenges in healthcare communication," said Giovanni Colella, MD, president and CEO of Healinx Corporation.

About Healinx
Healinx Corporation is the premier provider of Web-based, doctor-patient communication services. The Healinx service enables secure, clinically structured, and auditable communications between doctors and patients. Healinx helps doctors address their need to recoup income while providing efficient, secure online services to their patients. At the same time, Healinx offers patients convenience and access -- the convenience of communicating directly with their doctors at anytime from anyplace. By streamlining the doctor-patient relationship, Healinx enables payors to improve member satisfaction and retention and reduce their exposure to rising health care costs. For information, visit www.relayhealth.com.